the aid library

Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: A qualitative study

J. T. Galea; M. Wong; M. Muñoz; et al. PLOS ONE; PMC (2018) CC

Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018

CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment

Currier, J.S.; and D.V.Havlir (2017) CC

Topics in Antiviral Medicine 25 Issue 2 May/June 2017

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ... and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes

Mitchell, S.; Malanda, B.; Damasceno, A. et al. World Heart Federation (2019) CC

In 2014, the World Heart Federation (WHF) launched an initiative to develop a series of Roadmaps [1e6]. Their aim is to identify potential roadblocks on the pathway to effective prevention, detection, and management of cardiovascular disease (CVD ... more

Alzheimer’s disease - Clinical Review

Burns, A. and S. Iliffe BMJ (2009) C2

BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009) Cite this as: BMJ 2009;338:b158 Correspondence to: A Burns alistair.burns@manchester.ac.uk

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO

Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t ... more

HEARTS. Technical package for cardiovascular disease management in primary health care. Evidence-based treatment protocols

World Health Organization WHO, et al. (2018) C_WHO

In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles ... more

HEARTS. Technical package for cardiovascular disease management in primary health care. Implementation Guide

World Health Organization WHO, et al. (2018) C_WHO

HEARTS provides a set of locally adaptable tools for strengthening the management of CVD in primary health care. HEARTS is designed to enhance implementation of WHO PEN by providing: • operational guidance on further integrating CVD management • technical guidance on evaluating the impact of ... more

Active TB Disease

Minnesota Department of Health (2005) C1

National Guidelines for Antiretroviral Therapy
recommended

National AIDSSTD Program, Directorate General of Health Services; Ministry of Health and Family Welfare, Govt. of Bangladesh (2014) C1

Neglected Disease Research and Development: The Higher Cost of Lower Funding

G-Finder (2023) CC

Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go ... more

Clinical features of Chagas disease progression and severity

Nunes, M.C.P.; C. Bern, E.H. Clark, (2024) CC

The Lancet Regional Health Americas Volume 37100832 September 2024

Home-based therapeutic exercise as a treatment for Parkinson's Disease: an integrative review

Ihana Thaís Guerra de Oliveira Gondim; Carla Cabral dos Santos Accioly Lins; Maria das Graças Wanderley de Sales Coriolano Revista Brasileira de Geriatria e Gerontologia; SCIELO (2016) C2

Print version ISSN 1809-9823On-line version ISSN 1981-2256 Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016 http://dx.doi.org/10.1590/1809-98232016019.150040

Acute Chagas Disease: New Global Challenges for an Old Neglected Disease

Andrade, D.; Gollob, K.; Dutra, W. PLoS Neglected Tropical diseases (2015) CC

Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing p ... more

Guidelines for screening for Tuberculosis infection and disease during the domestic medical examination for newly arrived refugees

U.S. Department of Human Services; Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectios Diseases (2012) C_CDC

Division of Global Migration and Quarantine April 16, 2012

Implications of the Marburg virus disease outbreak in Rwanda for the EU/EEA, 2024

European Centre for Disease Prevention and Control (ecdc) (2024) C_CDC

This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in hu ... more